Anxiogenic activity of intraventricularly administered arginine vasopressin in the rat

Biogenic Amines

Volumn 14, Issue 4, 1998, Pages 367-385

  Bhattacharya, Salil K ^a   Bhttacharya, Arjnabh ^b,c   Chakrabarti, Amit ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c BOSE INSTITUTE   (India)

Author keywords

Acute water intoxication; Animal models; Anxiety; Arginine vasopressin; Pentylenetetrazol, pimozide; Tribulin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ARGIPRESSIN; LORAZEPAM; PENTETRAZOLE; PIMOZIDE; TRIBULIN; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FEEDING; HOMEOSTASIS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; SOCIAL INTERACTION; WATER INTOXICATION;

EID: 0031686222     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Andrews, J.S. and Stephens, D.N. (1990). Drug discrimination models in anxiety and depression. Pharmacol. Ther. 47, 267-280.
2. Antoni, F.A. (1993). Vasopressinergic control of pituitary adrenocroticotropin secretion comes of age. Front. Neuroendocrinol. 14, 76-122.
3. Bhattacharya, S.K. (1995). Anxiogenic action of centrally administered scorpion (Mesobuthus tamulus) venom in rats. Toxicon 33, 1491-1499.
4. Bhattacharya, S.K. and Acharya, S.B. (1993). Further investigations on the anxiogenic action of isatin. Biogenic Amines 9, 453-463.
5. Bhattacharya, S.K. and Acharya, S.B. (1994). Anxiogenic agents and 5-HT3 receptors. In : Recent advances in the study of neurotransmitter receptors. B.N. Dhawan, R.C. Srimal, R. Raghubir and R.S. Rapaka (Eds), Central Drug Research Institute, Lucknow, pp. 70-80.
6. Bhattacharya, S.K., Bhattacharya, A. and Ghosal, S. (1998a). Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy) : an experimental study. Biogenic Amines (in press).
7. Bhattacharya, S.K., Chakrabarti, A. and Glover, V (1998b). Stress and water balance : the roles of ANP, AVP and isatin. Indian J. Exp. Biol. (in press).
8. Bhattacharya, S.K. Chakrabarti, A., Sandler, M. and Glover, V. (1995a). Rat brain MAO A and MAO B inhibitory (tribulin) activity during drug withdrawal anxiety. Neurosci. Letts. 199, 103-106.
9. Bhattacharya, S.K., Chakrabarti, A., Sandler, M. and Glover, V. (1996a). Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsychopharmacol. 15, 199-206.
10. Bhattacharya, S.K., Chakrabarti, A., Sandler, M. and Glover, V. (1996b). Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity. Indian J. Exp. Biol. 34, 1190-1193.
11. Bhattacharya, S.K., Clow, A., Przyborowska, A., Halket, J., Glover, V. and Sandler, M. (1991a). Effect of aromatic amino acids, pentylenetetrazol and yohimbine on isatin and tribulin activity in rat brain. Neurosci. Letts. 132, 44-46.
12. Bhattacharya, S.K., Goel, R.K., Kaur, R. and Ghosal, S. (1987). Antistress activity of sitoindosides VII and VIII, two new acylsterylglucosides from Withania somnifera. Phytother. Res. 1, 32-37.
13. Bhattacharya, S.K. and Mitra, S.K. (1991b). Anxiogenic activity of Panax ginseng roots: an experimental study. J. Ethnopharmacol. 34, 87-92.
14. Bhattacharya, S.K., Mitra, S.K. and Acharya, S.B. (1991c). Anxiogenic action of isatin, a putative biological factor, in rodents. J. Psychopharmacol. 9, 202-206.
15. Bhattacharya, S.K., Mohan Rao, P.J.R. and Sen, A.P. (1995b). Anxiogenic activity of intraventricularly administered bradykinin in rats. J. Psychopharmacol. 9, 348-354.
16. Bhattacharya, S.K. and Satyan, K.S. (1997). Experimental methods for the evaluation of psychotropic agents in rodents. Antianxiety agents. Indian J. Exp. . Biol. 35, 565-575.
17. Bhattacharya, S.K., Satyan, K.S. and Chakrabarti, A. (1997). Anxiogenic action of caffeine : an experimental study in rats. J. Psychopharmacol. 11, 219-224.
18. Boanoff, S.R., Suranyi-Cadotte, B., Aitken, D.H., Quirion, R. and Meaney, M.J. (1988). The effects of chronic antidepressant treatment on an animal model of anxiety. Psychopharmacology 95, 298-302.
19. 3 receptors. Pharmacol. Ther 47, 181-202.
20. Delva, N.J., Crammer, J.L., Lawson, J.S., Lightman, S.L., Sribney, M. and Weir, B.J. (1990). Vasopressin in chronic psychiatric patients with primary polydipsia. Br. J. Psychiat. 157, 703-713.
21. File, S.E. (1980). The use of social interaction as a method for detecting anxiolytic action of chlordiazepoxide-like drugs. Neurosci. Methods. 2, 219-248.
22. Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Lim, A.T., Coplolov, D.L., Bennie, J., Carroll, S. and Dick, H. (1991). Atrial natriuretic peptide is a physiological inhibitor of ACTH release : evidence from immunoneutralisation in vivo. J. Endocrinol. 131, R 9-12.
23. Geyer, M.A. and Markou, A. (1995). Animal models of psychiatric disorders. In : Psychopharmacology : the fourth generation of progress. F.E. Bloom and D.J. Kupfer (Eds.), Raven Press, New York, pp. 787-798.
24. Gjerris, A., Hammer, M., Vendsborg, P., Christensen, M.J. and Rafaelsen, O.J. (1985). Cerebrospinal fluid vasopressin - changes in depression. Br. J. Psychiat. 147, 696-701.
25. Glover, V. and Sandler, M. (1993). Tribulin and isatin: an update. In : Monoamine oxidase : basic and clinical aspects. H. Yasuhara, S.N. Parvez, K. Oguchi, M. Sandler and T. Nagatsu (Eds.) VSP, Utrecht, pp. 61-71.
26. Glover, V., Bhattacharya, S.K. and Sandler, M. (1991). Isatin - a new biological factor. Indian J. Exp. Biol. 29, 1-5.
27. Gold, P.W., Goodwin, P.K. and Rous, V.I. (1978). Vasopressin in affective illness. Lancet 1, 1233-1236.
28. Hota, D. and Acharya, S.B. (1994). Studies on the peripheral actions of isatin. Indian J. Exp. Biol. 32, 710-717.
29. Jenner, P. and Marsden, G.D. (1983). Neuroleptics. In : Clinical Psychotherapy. H. Hippins and G. Winoker (Eds.) Excerpta Medica, Princeton, N.J. pp. 180-198.
30. Johnston, A.L., Baldwin, H.E. and File, S.E. (1988). Measures of anxiety and stress in the rat following chronic treatment with yohimbine. J. Psychopharmacol. 2, 33-38.
31. Lister, R.G. (1990). Ethologically based animal models of anxiety disorders. Pharmacol. Ther. 46, 321-340.
32. Lydiard, R.B. (1994). Neuropeptides and anxiety: focus on cholecystokinin. Clin. Chem. 40, 315-318.
33. Medvedev, A.E. Gorkin, V.Z., Fedotova, I.B. Semiokhina, A.F., Glover, V. and Sandler, M. (1992). Increase of endogenous monoamine oxidase inhibitory activity (tribulin) in experimental audiogenic seisures in rats: evidence for a monoamine, A inhibiting component of tribulin. Biochem. Pharmacol. 44, 1209-1210.
34. Nutt, D.J. (1990). The pharmacology of human anxiety. Pharmacol. Ther. 47, 233-266.
35. Ohsawa, H., Kishimoto, T., Shimayoshi, N., Matsumara, K., Tahara, K., Kitera, K., Hingashiura, N., Noriyama, Y., Matsumoto, H., Hirai, M. and Ikawa, G. (1993). Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients. Acta Psychiat. Scand. 88, 130-134.
36. Palit, G., Kumar, R., Patnaik, G.K. and Bhattacharya, S.K. (1997). Behavioural effects of isatin, a putative biological factor, in rhesus monkeys. Biogenic Amines 13, 131-142.
37. Pellow, S., Chopin, P., File, S.E. and Briley, M. (1985). Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
38. Raiteri, M., Paudice, P. and Vallebuona, F. (1993). Release of cholecystokinin in the central nervous system. Neurochem. Int. 22, 519-527.
39. Rinaman, L., Sherman, T.G. and Stricker, E.N. (1995). Vasopressin and oxytocin in the central nervous system. In : Psychopharmacology: the fourth generation of progress. F.E. Bloom and D.J. Kupfer (Eds.). Raven Press, New York, pp. 531-542.
40. Sahgal, A. (1984). A critique of the vasopressin-memory hypothesis. Psychopharmacology 83, 215-228.
41. Sandler, M. Clow, A., Watkins, P.J. and Glover, V. (1988). Tribulin - an endocoid marker for anxiety in man. Stress Med. 4, 215-219.
42. Sklar, A.H. and Scrier, R.W. (1983). Central nervous system mediators of vasopressin release. Physiol. Rev. 63, 1243-1280.
43. Swedo, S.E., Leonard, H.L., Kruesi, M.J., Rettew, D.C., Listwak, S.J., Berrettini, W., Stipetic, M., Hamurger, S., Gold, P.W. and Potter W.E. (1992). Cerebrospinal fluid chemistry in children and adolescents with obsessive-compulsive disorder. Arch. Gen. Psychiat. 49, 29-36.
44. Triet, D. (1985). Animal models for the study of antianxiety agents: a review. Neurosci. Biobehav. Rev. 9, 203-222.